- Home
- CBSH vs KNSA Comparison
CBSH vs KNSA Comparison
Compare CBSH & KNSA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | CBSH | KNSA |
|---|---|---|
| Founded | 1865 | 2015 |
| Country | United States | United Kingdom |
| Employees | N/A | N/A |
| Industry | Major Banks | Biotechnology: Pharmaceutical Preparations |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 8.0B | 7.7B |
| IPO Year | 2008 | 2018 |
Fundamental Metrics
Financial Performance| Metric | CBSH | KNSA |
|---|---|---|
| Price | $55.65 | $96.11 |
| Analyst Decision | Hold | Strong Buy |
| Analyst Count | 10 | 7 |
| Target Price | $64.06 | ★ $109.43 |
| AVG Volume (30 Days) | ★ 952.3K | 943.8K |
| Earning Date | 10-20-2026 | 10-27-2026 |
| Dividend Yield | ★ 1.98% | N/A |
| EPS Growth | 4.39 | ★ 225.00 |
| EPS | ★ 3.14 | 1.14 |
| Revenue | N/A | ★ $677,564,000.00 |
| Revenue This Year | $12.04 | $54.96 |
| Revenue Next Year | $3.42 | $24.16 |
| P/E Ratio | ★ $17.66 | $84.26 |
| Revenue Growth | N/A | ★ 60.09 |
| 52 Week Low | $46.99 | $37.02 |
| 52 Week High | $60.92 | $99.31 |
Technical Indicators
Market Signals| Indicator | CBSH | KNSA |
|---|---|---|
| Relative Strength Index (RSI) | 49.67 | 59.87 |
| Support Level | $54.23 | $72.76 |
| Resistance Level | $56.26 | $98.48 |
| Average True Range (ATR) | 1.04 | 5.13 |
| MACD | 0.05 | 0.28 |
| Stochastic Oscillator | 37.69 | 80.18 |
Price Performance
Historical ComparisonAbout CBSH Commerce Bancshares Inc.
Commerce Bancshares Inc operates as the bank holding company for Commerce Bank. The bank is engaged in the general banking business, providing a broad range of retail, mortgage banking, corporate, investment, trust, and asset management products and services to individuals, businesses, and municipalities. The company has three reportable segments. The Commercial segment provides lending, leasing, deposit, payment, and cash management services to business and government customers. The Retail Banking segment offers consumer deposits, consumer lending, mortgage banking, and debit and credit card services through its branch network. The Wealth segment provides trust, estate planning, brokerage, and investment management services to individual and institutional clients.
About KNSA Kiniksa Pharmaceuticals Ltd.
Kiniksa Pharmaceuticals International PLC is a clinical-stage biopharmaceutical company focused on discovering, acquiring, developing, and commercializing therapeutic medicines for patients suffering from debilitating cardiovascular diseases. The company's clinical-stage product candidates include Rilonacept, abiprubart, and Vixarelimab. Geographically, the company earns maximum revenue from United States.